Design
Review
Authors
Loading...
Does not yet support clinical use of RNA-targeting small molecules; leaves open their potential in viral diseases pending rigorous trials.
Key points are not available for this paper at this time.
Wilson et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: